• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareHealthcare Equipment & SuppliesSpyGlass Pharma
    Picture of SpyGlass Pharma logo

    SGP — SpyGlass Pharma News Story

    $24.720.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    • Market Cap
      $826.83m
    • Enterprise Value
      $592.65m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SGP Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SGP Dividends
    All News

    NASDAQ RESUMED AT 12:13 PM

    Picture of SpyGlass Pharma logoSpyGlass Pharma
    06/02/2026 17:13
    NASDAQ RESUMED  SGP.O  AT 12:13 PM
    

    Recent news on SpyGlass Pharma

    See all news
    • Brief: Spyglass Pharma Announces Positive 4-Year Data From First-In-Human Trial Of BIM-Iol System

      Mon 13:58
    • SpyGlass Pharma Q2 net loss widens on higher expenses

      06/08/2026 21:21
    • Brief: Spyglass Pharma Inc - BIM-Iol System Phase 3 Trial Enrollment Expected To Complete In 2027

      18/05/2026 14:02
    • Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO (updated)

      23/02/2026 11:54
    • NASDAQ RESUMED AT 01:46 PM

      06/02/2026 18:46

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.